Balance Sheet Details - Schedule of Accrued Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Accrued Liabilities, Current [Abstract]
Accrued compensation	$ 7,802	$ 3,578
Cystic Fibrosis Foundation Liability (Note 9)		2,777
Current portion of operating lease liability	3,783	1,537
Clinical accruals	2,026	8,675
Vinbiocare contractual liabilities	5,896
Other accrued research and development expenses	6,022	6,956
Total	$ 25,529	$ 23,523